HeartSciences Inc. (HSCSW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
分析师预估 每股收益(EPS)为 $-20.00 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-18.74 vs 预期 $-20.00 (超预期 +6.3%). 2025: 实际 $-9.34 vs 预期 $-9.09 (不及预期 -2.8%). 分析师准确度: 95%.
EPS 预测 — HSCSW
95%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$18.74
vs Est –$20.00
▲ 6.7% off
2025
Actual –$9.34
vs Est –$9.09
▼ 2.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
营收预测 — HSCSW
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.000B
vs Est $0.000B
▼ 168.8% off
2025
Actual $0.000B
vs Est $0.000B
▼ 1,049.4% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
